Market Summary
USD488.36+3.50
Market Closed0.72%
HUM Stock Price
HUM RSI Chart
HUM Valuation
HUM Price/Sales (Trailing)
HUM Profitability
HUM Fundamentals
HUM Revenue
HUM Earnings
Price Action
52 Week Range
410.17571.30
(Low)(High)
Last 7 days
-2.5%
Last 30 days
-4.1%
Last 90 days
-5.3%
Trailing 12 Months
11.1%
HUM Financial Health
HUM Investor Care
Peers (Alternatives to Humana)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
UNH | 439.0B | 324.2B | -3.12% | -7.42% | 21.82 | 1.35 | 12.71% | 16.40% |
CI | 91.1B | 180.5B | -13.92% | 6.07% | 13.64 | 1.92 | 3.70% | 24.58% |
HUM | 61.8B | 92.9B | -4.10% | 11.05% | 22.03 | 0.67 | 11.81% | -4.33% |
CNC | 35.3B | 144.5B | -9.19% | -25.06% | 29.38 | 0.24 | 14.74% | -10.76% |
| MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 4.9B | 831.2M | -10.57% | -12.87% | -83.44 | 5.9 | 12.11% | -862.52% |
AMN | 3.4B | 5.2B | -8.25% | -21.56% | 7.71 | 0.65 | 31.60% | 35.63% |
CRVL | 3.2B | 704.5M | 4.54% | 11.22% | 47.88 | 4.61 | 13.56% | 10.15% |
PDCO | 2.6B | 6.4B | -2.27% | -16.61% | 13.15 | 0.4 | -0.52% | 17.01% |
| SMALL-CAP | ||||||||
ADUS | 1.7B | 951.1M | -1.69% | 17.81% | 36.04 | 1.74 | 10.02% | 1.99% |
TVTY | 1.6B | - | 0.59% | 17.88% | 18.77 | 3.24 | - | - |
RDNT | 1.3B | 1.4B | 14.63% | 3.78% | 123.09 | 0.92 | 8.74% | -56.93% |
BKD | 561.7M | 2.8B | -12.95% | -59.69% | -2.36 | 0.2 | 2.43% | -140.13% |
Financials for Humana
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.5% | 92,870 | 91,485 | 89,383 | 86,366 | 83,064 |
| S&GA Expenses | 1.2% | 12,671 | 12,515 | 12,057 | 11,000 | 10,121 |
| EBITDA | 0.6% | 4,718 | 4,690 | 4,989 | 4,590 | - |
| EBITDA Margin | -0.9% | 0.05* | 0.05* | 0.06* | 0.05* | - |
| Earnings Before Taxes | -0.3% | 3,568 | 3,579 | 3,918 | 3,534 | 3,354 |
| EBT Margin | -1.8% | 0.04* | 0.04* | 0.05* | 0.04* | - |
| Interest Expenses | 4.4% | 401 | 384 | 370 | 348 | 326 |
| Net Income | 0.0% | 2,806 | 2,807 | 3,143 | 3,035 | 2,933 |
| Net Income Margin | -1.5% | 0.03* | 0.03* | 0.04* | 0.04* | - |
| Free Cahsflow | -58.7% | 3,467 | 8,385 | 2,729 | 2,080 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | -15.2% | 43,055 | 50,765 | 46,820 | 46,308 | 44,358 |
| Current Assets | -22.3% | 26,183 | 33,711 | 27,217 | 26,840 | 24,893 |
| Cash Equivalents | -62.7% | 5,061 | 13,558 | 5,153 | 4,864 | 3,394 |
| Net PPE | 0.1% | 3,221 | 3,218 | 3,121 | 3,189 | 3,073 |
| Goodwill | 0.5% | 9,142 | 9,096 | 8,911 | 11,139 | 11,092 |
| Liabilities | -19.6% | 27,685 | 34,448 | 31,310 | 30,966 | 28,255 |
| Current Liabilities | -31.4% | 17,178 | 25,051 | 17,839 | 17,532 | 15,331 |
| LT Debt, Non Current | 15.9% | 9,034 | 7,798 | 11,290 | 11,285 | 10,541 |
| Shareholder's Equity | -6.2% | 15,311 | 16,317 | 15,510 | 15,342 | 16,080 |
| Retained Earnings | -0.4% | 25,492 | 25,606 | 24,511 | 23,915 | 23,086 |
| Additional Paid-In Capital | 0.4% | 3,246 | 3,234 | 3,153 | 3,103 | 3,082 |
| Accumulated Depreciation | - | 2,874 | - | - | - | - |
| Shares Outstanding | 0.0% | 127 | 127 | 126 | - | - |
| Minority Interest | -6.3% | 59.00 | 63.00 | 20.00 | 23.00 | 23.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -52.3% | 4,587 | 9,618 | 4,000 | 3,401 | 2,262 |
| Share Based Compensation | -2.3% | 216 | 221 | 189 | 184 | 180 |
| Cashflow From Investing | -947.9% | -1,006 | -96.00 | -6,023 | -5,716 | -6,556 |
| Cashflow From Financing | -614.2% | -1,914 | -268 | 3,865 | 3,302 | 3,015 |
| Dividend Payments | 2.6% | 392 | 382 | 372 | 362 | 354 |
| Buy Backs | 95.0% | 2,096 | 1,075 | 1,074 | 1,073 | 79.00 |
Risks for HUM
What is the probability of a big loss on HUM?
58.5%
Probability that Humana stock will be more than 20% underwater in next one year
19.2%
Probability that Humana stock will be more than 30% underwater in next one year.
0%
Probability that Humana stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does HUM drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Humana was unfortunately bought at previous high price.
Drawdowns
Returns for HUM
Cumulative Returns on HUM
22.4%
10-Year Cumulative Returns
15.5%
7-Year Cumulative Returns
13.2%
5-Year Cumulative Returns
18.5%
3-Year Cumulative Returns
What are the long-term rolling returns for HUM?
FIve years rolling returns for Humana.
Annualized Returns
Which funds bought or sold HUM recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-28 | Acrisure Capital Management, LLC | new | - | 585,433 | 585,433 | 0.65% |
2023-03-24 | Longbow Finance SA | new | - | 15,333,900 | 15,333,900 | 2.06% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.83 | 658,244 | 18,754,900 | 0.15% |
2023-03-17 | American Portfolios Advisors | reduced | -7.59 | -18,687 | 425,047 | 0.02% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 8.63 | 99,705 | 774,705 | 0.02% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -7.18 | -1,818,050 | 88,317,900 | 0.10% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | 1,170 | 28,170 | -% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 3.15 | 23,316 | 223,316 | 0.02% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | reduced | -0.24 | 53,794 | 1,062,790 | 0.07% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 4.14 | 274,000 | 3,028,000 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Humana News
Schedule 13G FIlings of Humana
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | price t rowe associates inc /md/ | 6.0% | 7,623,150 | SC 13G/A | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 8.97% | 11,357,974 | SC 13G/A | |
| Feb 06, 2023 | wellington management group llp | 6.01% | 7,611,181 | SC 13G | |
| Jan 25, 2023 | blackrock inc. | 9.2% | 11,628,073 | SC 13G/A | |
| Jun 09, 2022 | blackrock inc. | 10.1% | 12,733,508 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 8.1% | 10,508,002 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 7.79% | 10,008,322 | SC 13G/A | |
| Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 8.8% | 11,254,355 | SC 13G/A |
HUM Fair Value
Humana fair value in different scenarios
The table shows the Fair Value estimates for Humana for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | - - | - - | - - | - - | - - |
| Current Inflation | 287.83 -41.06% | 417.26 -14.56% | 616.10 26.16% | 806.15 65.07% | 935.13 91.48% |
| Very High Inflation | - - | - - | - - | - - | - - |
Historical Humana Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Humana
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 27, 2023 | 3 | Insider Trading | |
| Mar 23, 2023 | 4 | Insider Trading | |
| Mar 13, 2023 | 8-K | Current Report | |
| Mar 08, 2023 | ARS | ARS | |
| Mar 08, 2023 | DEF 14A | DEF 14A | |
| Mar 08, 2023 | DEFA14A | DEFA14A | |
| Mar 03, 2023 | 4 | Insider Trading | |
| Mar 02, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 424B5 | Prospectus Filed | |
| Mar 01, 2023 | 8-K | Current Report |
Latest Insider Trading transactions for HUM
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-01 | Feinberg David T | acquired | - | - | 441 | - |
2023-02-28 | JONES DAVID A JR/KY | gifted | - | - | -10,000 | - |
2023-02-27 | Ventura Joseph C | gifted | - | - | -69.00 | chief legal officer |
2023-02-27 | BROUSSARD BRUCE D | sold | -8,890,230 | 505 | -17,575 | president & ceo |
2023-02-27 | Huval Timothy S. | sold | -1,341,080 | 510 | -2,628 | chief administrative officer |
2023-02-27 | Ventura Joseph C | sold | -1,040,330 | 507 | -2,048 | chief legal officer |
2023-02-24 | BROUSSARD BRUCE D | acquired | - | - | 28,494 | president & ceo |
2023-02-24 | Huval Timothy S. | acquired | - | - | 4,306 | chief administrative officer |
2023-02-24 | BROUSSARD BRUCE D | sold (taxes) | -5,571,340 | 510 | -10,919 | president & ceo |
2023-02-24 | Fleming William Kevin | sold (taxes) | -919,457 | 510 | -1,802 | seg pres, pharmacy sol & ccao |
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Income Statement
2022-12-31CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Income Statement [Abstract] | |||
| Services | Health Care [Member] | Health Care [Member] | Health Care [Member] |
| Revenues: | |||
| Premiums | $ 87,712 | $ 79,822 | $ 74,186 |
| Services | 4,776 | 3,055 | 1,815 |
| Investment income | 382 | 187 | 1,154 |
| Total revenues | 92,870 | 83,064 | 77,155 |
| Operating expenses: | |||
| Benefits | 75,690 | 69,199 | 61,628 |
| Operating costs | 12,671 | 10,121 | 10,052 |
| Depreciation and amortization | 709 | 596 | 489 |
| Total operating expenses | 89,070 | 79,916 | 72,169 |
| Income from operations | 3,800 | 3,148 | 4,986 |
| Gain on sale of KAH Hospice | (237) | 0 | 0 |
| Interest expense | 401 | 326 | 283 |
| Other expense (income), net | 68 | (532) | 103 |
| Income before income taxes and equity in net (losses) earnings | 3,568 | 3,354 | 4,600 |
| Provision for income taxes | 762 | 485 | 1,307 |
| Equity in net (losses) earnings | (4) | 65 | 74 |
| Net income | 2,802 | 2,934 | 3,367 |
| Net loss (income) attributable to noncontrolling interests | 4 | (1) | 0 |
| Net income attributable to Humana | $ 2,806 | $ 2,933 | $ 3,367 |
| Basic earnings per common share (in dollars per share) | $ 22.20 | $ 22.79 | $ 25.47 |
| Diluted earnings per common share (in dollars per share) | $ 22.08 | $ 22.67 | $ 25.31 |
HUM Balance Sheet
2022-12-31CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 5,061 | $ 3,394 |
| Investment securities | 13,881 | 13,192 |
| Receivables, net of allowances of $70 in 2022 and $83 in 2021 | 1,674 | 1,814 |
| Other current assets | 5,567 | 6,493 |
| Total current assets | 26,183 | 24,893 |
| Property and equipment, net | 3,221 | 3,073 |
| Long-term investment securities | 380 | 780 |
| Goodwill | 9,142 | 11,092 |
| Equity method investments | 749 | 141 |
| Other long-term assets | 3,380 | 4,379 |
| Total assets | 43,055 | 44,358 |
| Current liabilities: | ||
| Benefits payable | 9,264 | 8,289 |
| Trade accounts payable and accrued expenses | 5,238 | 4,509 |
| Book overdraft | 298 | 326 |
| Unearned revenues | 286 | 254 |
| Short-term debt | 2,092 | 1,953 |
| Total current liabilities | 17,178 | 15,331 |
| Long-term debt | 9,034 | 10,541 |
| Other long-term liabilities | 1,473 | 2,383 |
| Total liabilities | 27,685 | 28,255 |
| Commitments and contingencies (Note 17) | ||
| Stockholders' Equity: | ||
| Preferred stock, $1 par; 10,000,000 shares authorized; none issued | 0 | 0 |
| Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021 | 33 | 33 |
| Capital in excess of par value | 3,246 | 3,082 |
| Retained earnings | 25,492 | 23,086 |
| Accumulated other comprehensive (loss) income | (1,304) | 42 |
| Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021 | (12,156) | (10,163) |
| Total stockholders' equity | 15,311 | 16,080 |
| Noncontrolling interests | 59 | 23 |
| Total equity | 15,370 | 16,103 |
| Total liabilities and equity | $ 43,055 | $ 44,358 |